Correction to “The In Vitro Effect of Psoralen on Glioma Based on Network Pharmacology and Potential Target Research”
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1
Figure 2
Figure 3Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsBioactive natural compounds · Plant chemical constituents analysis · Cancer, Stress, Anesthesia, and Immune Response
Y. Wu, Y.‐Z. Zhang, M.‐J. Li, W. Yang, and L.‐F. Cheng, “The In Vitro Effect of Psoralen on Glioma Based on Network Pharmacology and Potential Target Research,” Evidence-Based Complementary and Alternative Medicine 2022, no. 1 (2022): 1–10, https://doi.org/10.1155/2022/1952891.
In the Results section, Figure 5a was incorrect. During the preparation of the manuscript, panels 0 μm U251, 10 μm U87, and 30 μm U251 were mistakenly uploaded in duplicate. The correct Figure 5 is shown below:
We apologize for this error.